Medscape

First-in-Human Trial Supports Safety, Feasibility of Stem Cell Therapy in Prenatal Spina Bifida Repair

A first-in-human trial shows the feasibility and safety of delivering placenta-derived stem cells during prenatal ...

First-ever in-utero stem cell therapy for fetal spina bifida repair shows safe results

A Phase I clinical trial published in The Lancet has shown that combining stem cell therapy with standard fetal surgery ...
Medscape

First Embryonic Stem-Cell-Based Therapy Trial in Spinal-Cord Injury Gets FDA Nod

January 27, 2009 — Geron Corp announced it has received US Food and Drug Administration (FDA) approval for a phase 1 trial of GRNOPC1, a cell therapy derived from human embryonic stem cells (hESC), in ...
PharmiWeb

Stem Cell Therapy Market Research Report, Analysis. Demand by Region, Growth, Size, Share and Forecast to 2029

The global stem cell therapy market is projected to experience robust growth, with an expected annual growth rate of 20% by 2029. Key drivers behind this expansion include a favorable investment ...
The Lancet

Safeguarding genomic integrity in pluripotent stem-cell therapies

Human pluripotent stem-cells (HPSCs)—including human embryonic stem-cells and human induced pluripotent stem-cells—are reshaping the landscape of regenerative medicine.1,2 In Parkinson's disease, ...
Business Wire

Curing the Incurable with ‘Biological Age Zero’ Cells: Clonell™ Launches the Ultimate Regenerative Medicine Platform

Fundamental Cure for Intractable and Incurable Diseases using ‘Biological Age Zero’ Cells Derived from Patient’s Own Cells via SCNT Technology World's First Therapy Platform Simultaneously Solving ...